Pharmaceuticals, Biotechnology and Life Sciences
Cash balance of $301.2M expected to fund operations into 2025CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) — Generation Bio Co.…
UTRECHT, The Netherlands and PHILADELPHIA, Nov. 03, 2022 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical stage immuno-oncology…
BOULDER, Colo., Nov. 03, 2022 (GLOBE NEWSWIRE) — Fresh Tracks Therapeutics, Inc. (“Fresh Tracks Therapeutics” or the “Company”) (Nasdaq: FRTX),…
Management to host conference call and webcast at 4:30 pm ETIRVINE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals,…
Data From CPI-818 T Cell Lymphoma Study Accepted for Presentation at the 64th ASH Annual Meeting and Exposition; Advancing CPI-818…
— NUZYRA® (omadacycline) Generated Net U.S. Sales of $25.5 Million from the Core Commercial Business, a 31% increase from $19.4…
ROCKVILLE, Md., Nov. 03, 2022 (GLOBE NEWSWIRE) — Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage…
Reiterates 2022 Total Revenue Guidance of $135M-$141M, Including Product Revenues of $112M-$118MREDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) — Codexis,…
SUNNYVALE, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the…
HOLLISTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third…